Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Veronica Hackethal, MD
The anticonvulsant known as Potiga (ezogabine) in the US and as Trobalt (retigabine) in Europe will be discontinued by the manufacturer at the end of June. Details here.
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.
Here is new evidence that the incidence of SUDEP is higher than expected in boys, people with psychiatric comorbidities, and other groups. Details here.
These mobile apps provide tools to record medication details and reminders, first aid instructions, step-by-step recovery guides, and other topics of concern for you and your patient.
Researchers tested the accuracy of the Movement Disorder Society’s criteria for diagnosing Parkinson disease.
Medications to treat dementia can improve behavioral symptoms, but have risks. Music therapy, however, offers a low-cost, nonpharmacological option.
To estimate just how much treatment delays impact the effectiveness of endovascular therapy, researchers constructed a model using data from various sources.
A study tested four different efficacy criteria for comparing intravenous antiepileptic drugs (AEDs) used to end status epilepticus.
The first study of its kind in Australia examined influenza-associated neurological disease in hospitalized children.